PL358272A1 - Sposoby hamowania angiogenezy i wzrostu guza - Google Patents

Sposoby hamowania angiogenezy i wzrostu guza

Info

Publication number
PL358272A1
PL358272A1 PL01358272A PL35827201A PL358272A1 PL 358272 A1 PL358272 A1 PL 358272A1 PL 01358272 A PL01358272 A PL 01358272A PL 35827201 A PL35827201 A PL 35827201A PL 358272 A1 PL358272 A1 PL 358272A1
Authority
PL
Poland
Prior art keywords
methods
tumor growth
inhibiting angiogenesis
angiogenesis
inhibiting
Prior art date
Application number
PL01358272A
Other languages
English (en)
Inventor
Dale L. Boger
David A. Cheresh
Original Assignee
The Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Scripps Research Institute filed Critical The Scripps Research Institute
Publication of PL358272A1 publication Critical patent/PL358272A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL01358272A 2000-03-27 2001-03-27 Sposoby hamowania angiogenezy i wzrostu guza PL358272A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19226000P 2000-03-27 2000-03-27

Publications (1)

Publication Number Publication Date
PL358272A1 true PL358272A1 (pl) 2004-08-09

Family

ID=22708924

Family Applications (2)

Application Number Title Priority Date Filing Date
PL366316A PL205134B1 (pl) 2000-03-27 2001-03-27 Pochodne glicylolizyny, preparat farmaceutyczny i zastosowanie pochodnych glicylolizyny
PL01358272A PL358272A1 (pl) 2000-03-27 2001-03-27 Sposoby hamowania angiogenezy i wzrostu guza

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL366316A PL205134B1 (pl) 2000-03-27 2001-03-27 Pochodne glicylolizyny, preparat farmaceutyczny i zastosowanie pochodnych glicylolizyny

Country Status (15)

Country Link
EP (2) EP1272173A4 (pl)
JP (2) JP2003528850A (pl)
KR (2) KR100767616B1 (pl)
CN (2) CN1229339C (pl)
AU (4) AU2001249499B2 (pl)
CA (3) CA2403630C (pl)
CZ (2) CZ20023510A3 (pl)
HU (2) HUP0301621A3 (pl)
MX (2) MXPA02009504A (pl)
NO (2) NO20024576L (pl)
PL (2) PL205134B1 (pl)
RU (2) RU2269339C2 (pl)
SK (2) SK14852002A3 (pl)
WO (2) WO2001072297A1 (pl)
ZA (2) ZA200208628B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2235611B2 (es) * 2003-07-25 2006-07-16 Universidade De Santiago De Compostela Metodo cuantitativo para la deteccion de yesotoxinas en productos pesqueros basado en la activacion que producen en las fosfodiesterasas.
UA82561C2 (uk) 2003-10-23 2008-04-25 Оцука Фармасьютикалз Ко., Лтд. Стерильна ін'єкційна композиція арипіпразолу з контрольованим вивільненням, спосіб її виготовлення та спосіб лікування шизофренії
RU2287341C1 (ru) * 2005-03-01 2006-11-20 Автономная некоммерческая организация Научно-технический центр "Фармбиопресс" Ингибитор ангиогенеза, антиангиогенная фармацевтическая композиция на его основе и способ лечения злокачественных новообразований
SI2170279T1 (en) 2007-07-31 2018-04-30 Otsuka Pharmaceutical Co., Ltd. Methods for producing aripiprazole suspension and freeze-dried formulation
RU2404794C2 (ru) * 2008-11-27 2010-11-27 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) Вагинальные суппозитории для лечения рака шейки матки

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
JPH05125029A (ja) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
UA44258C2 (uk) * 1993-10-15 2002-02-15 Рон-Пуленк Рорер Фармасьютікалз Інк. Антитромботичні азациклоалкілалканоілпептиди та псевдопептиди, фармацевтична композиція, що їх містить, спосіб профілактики або лікування тромбозу у ссавців (варіанти)
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
JP2002514180A (ja) * 1996-09-04 2002-05-14 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法
EP0968423A4 (en) * 1997-02-07 2002-10-30 Scripps Research Inst CONVERGENT SYNTHESIS OF A COMBINATORY LIBRARY
JP2002509881A (ja) * 1998-03-27 2002-04-02 ジェネンテク・インコーポレイテッド Ｃｄ１１／ｃｄ１８接着レセプター媒介疾患の治療用アンタゴニスト

Also Published As

Publication number Publication date
NO20024576L (no) 2002-11-20
AU2001249499B2 (en) 2005-04-21
HUP0301621A2 (hu) 2003-09-29
NO328969B1 (no) 2010-06-28
KR20020084258A (ko) 2002-11-04
CA2659030A1 (en) 2001-10-04
EP1272173A4 (en) 2006-05-03
CA2403871A1 (en) 2001-10-04
CN1229339C (zh) 2005-11-30
HUP0301621A3 (en) 2009-06-29
KR100776185B1 (ko) 2007-11-16
NO20024576D0 (no) 2002-09-24
AU5101801A (en) 2001-10-08
CZ20023509A3 (cs) 2003-06-18
NO20024578L (no) 2002-11-20
SK14842002A3 (sk) 2003-04-01
CN1245967C (zh) 2006-03-22
AU2001251018B2 (en) 2005-12-01
ZA200208626B (en) 2004-02-16
CA2403871C (en) 2010-05-11
EP1272173A1 (en) 2003-01-08
AU4949901A (en) 2001-10-08
WO2001072297A1 (en) 2001-10-04
CA2403630C (en) 2009-05-26
NO20024578D0 (no) 2002-09-24
PL205134B1 (pl) 2010-03-31
ZA200208628B (en) 2004-02-12
JP2003528850A (ja) 2003-09-30
CN1429106A (zh) 2003-07-09
SK14852002A3 (sk) 2003-06-03
KR100767616B1 (ko) 2007-10-18
MXPA02009510A (es) 2003-05-21
HUP0301797A3 (en) 2010-09-28
EP1276713A1 (en) 2003-01-22
PL366316A1 (pl) 2005-01-24
CA2403630A1 (en) 2001-10-04
JP2003528140A (ja) 2003-09-24
EP1276713A4 (en) 2006-05-03
RU2276133C2 (ru) 2006-05-10
CN1441777A (zh) 2003-09-10
CZ20023510A3 (cs) 2003-03-12
WO2001072699A1 (en) 2001-10-04
HUP0301797A2 (hu) 2003-09-29
MXPA02009504A (es) 2003-05-21
RU2269339C2 (ru) 2006-02-10
KR20020091156A (ko) 2002-12-05
RU2002128751A (ru) 2004-03-10

Similar Documents

Publication Publication Date Title
HUP0105155A3 (en) Methods for inhibiting brain tumor growth
CA98770S (en) Pantiliner
EP1223932A4 (en) COMPOUNDS AND METHODS
EP1146790A4 (en) COMPOUNDS AND METHODS
EP1605961A4 (en) POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH
EP1313477A4 (en) COMPILATIONS AND METHODS
EP1274424A4 (en) CONNECTIONS AND PROCEDURE
AU4949901A (en) Methods for inhibiting angiogenesis and tumor growth
EP1343796A4 (en) COMPOUNDS AND METHODS
GB0026015D0 (en) Cancer treatment
GB2364078B (en) Ground treatment
AU6600400A (en) Methods and means for inhibiting angiogenesis
GB2367018B (en) Growth cutters
GB0016693D0 (en) Cough treatment
GB0118880D0 (en) Compostions and methods for controlling molluscs
GB0024510D0 (en) Methods
GB0007989D0 (en) Methods
GB0102454D0 (en) Methods
GB0021859D0 (en) Methods
GB9923117D0 (en) Insect-paper and methods for its formation and use
GB0000829D0 (en) Growth inhibitor
CA90931S (en) Pantiliner
CA87066S (en) Coffee marker
AU6884801A (en) Therapeutic compounds and methods
GB0020086D0 (en) Barrow insert

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)